VivaQuant provides comprehensive and cost-effective ECG analysis services for evaluation of arrhythmia liability and quantification of arrhythmias and intervals in clinical and preclinical research studies. Our ECG services are based on our revolutionary Rhythm ExpressTM software with MDSPTM technology that eliminates 95 percent of noise while preserving fidelity, thus enabling highly sensitive and accurate measurements from continuous ambulatory ECGs where signal corruption and artifact are often problematic. Rhythm Express is also available for client use via a cloud-based subscription.

VivaQuant technology shows promise for improving drug safety assessment accuracy

June 2018   Read more >

Meet VivaQuant at the Society of Toxicology 2018 in San Antonio

March 12-14, 2018   Read more >

LIVE WEBINAR: Improving Preclinical and Clinical Regulatory Submissions Through Enhanced ECG Interval and Arrhythmia Assessment

March 1st, 2018   Read more >

VivaQuant Rhythm Express software demonstrates improved accuracy of cardiac safety assessment markers

December 2017   Read more >

VivaQuant and DSI Announce Agreement

September 2017   Read more >

ECG Services

VivaQuant provides continuous beat-to-beat analysis services for ambulatory ECGs from preclinical and clinical research studies. Services include restitution analysis, predictive modeling, and complex statistics.

More information >

ECG Analysis Software

VivaQuant AE-1010 software for arrhythmia and beat-to-beat interval analysis of preclinical ECGs is fast, accurate, easy to learn, and easy to validate - saving you time and money. Process a 24-hour recording in 10-20 seconds.

More information >

Technology Licensing

VivaQuant licenses MDSP technology for select fields of use and is available for both Windows PC platforms and ultra-low-power ARM Cortex embedded platforms for heart rate measurement and arrhythmia detection.

More information >

© 2018 VivaQuant, LLC | Sitemap